DIFFERENTIAL RATES OF DOWN REGULATION AND RECOVERY OF RAT MYOCARDIAL BETA-ADRENOCEPTOR SUBTYPES INVIVO

被引:28
作者
LU, XY [1 ]
BARNETT, DB [1 ]
机构
[1] UNIV LEICESTER,DEPT PHARMACOL & THERAPEUT,LEICESTER LE1 7RH,ENGLAND
关键词
Agonist-induced regulation; Isoprenaline; Myocardium (rat); β-Adrenoceptor subtypes;
D O I
10.1016/0014-2999(90)90045-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have investigated the differential rate and extent of down regulation and recovery of rat myocardial β adrenoceptor subtypes during and after short term (up to 72 h) subcutaneous isoprenaline infusions (40 μg/kg per h) in vivo using osmotic minipumps. Maximum density (Bmax) of the receptors in ventricular membranes was assessed by radioligand binding, saturation analysis using 125I-pindolol. Groups of animals were sacrificied following various agonist infusion times and then during recovery after removal of minipumps following initial infusion of isoprenaline for 72 h. During agonist infusion, β2 adrenoceptors down regulated significantly more rapidly and to a greater extent than the β1 subtype (maximum change from control 66% β2, 34% β1 P < 0.05). In the recovery phase of the experiments following initial maximum down regulation, β2 adrenoceptor density also returned to control values more rapidly (by 24 h) than the β1 subtype (> 72 h). These results are qualitatively different to those reported in other tissues from this species using selective and non selective catecholamine agonists and in human myocardium in end stage heart failure following chronic sympathetic nervous stimulation. This may be due to differences in tissue cellular composition, the nature/selectivity of the agonist or the length of time of agonist exposure. © 1990.
引用
收藏
页码:481 / 486
页数:6
相关论文
共 16 条
[1]  
BAROVSKY K, 1980, J CYCLIC NUCL PROT, V6, P297
[2]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[3]  
BRISTOW MR, 1984, CIRCULATION, V70, P268
[4]  
CHANG HY, 1982, J PHARMACOL EXP THER, V221, P784
[5]  
CHEUNG YD, 1984, BIOCHEM PHARMACOL, V33, P1293
[6]  
COHEN ML, 1981, J CARDIOVASC PHARM, V10, P365
[7]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[8]   (-)-[I-125]PINDOLOL BINDING TO THE HUMAN-PLATELET BETA-ADRENOCEPTOR - CHARACTERIZATION AND AGONIST INTERACTIONS [J].
COOK, N ;
NAHORSKI, SR ;
BARNETT, DB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 113 (02) :247-254
[9]  
DOOLEY DJ, 1984, P C IUPHAR LONDON
[10]  
HAYES JS, 1984, J PHARMACOL EXP THER, V231, P633